Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase
- 25 September 2000
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (9) , 1251-1265
- https://doi.org/10.1016/s0006-2952(00)00408-1
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of nni-resistant and multidrug-resistant human immunodeficiency virus-1Bioorganic & Medicinal Chemistry Letters, 1999
- Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. KarnJournal of Molecular Biology, 1998
- Efficacy, Pharmacokinetics, andin VivoAntiviral Activity of UC781, a Highly Potent, Orally Bioavailable Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1AIDS Research and Human Retroviruses, 1997
- Anti-HIV Active Naphthyl Analogues of HEPT and DABO.Acta Chemica Scandinavica, 1997
- Phenethylthiazolethiourea (PETT) Compounds, a New Class of HIV-1 Reverse Transcriptase Inhibitors. 1. Synthesis and Basic Structure-Activity Relationship Studies of PETT AnalogsJournal of Medicinal Chemistry, 1995
- Molecular modeling studies of HIV‐1 reverse transcriptase nonnucleoside inhibitors: Total energy of complexation as a predictor of drug placement and activityProtein Science, 1995
- A Unified Polymerase Mechanism for Nonhomologous DNA and RNA PolymerasesScience, 1994
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994
- Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodiesNature, 1990
- Solvent-Accessible Surfaces of Proteins and Nucleic AcidsScience, 1983